Serum vitamin D and the risk of SARS-CoV-2 and seasonal influenza infection during the twindemic period.

Publication date: Aug 01, 2025

The association between circulating vitamin D levels and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or seasonal influenza infection in vaccine recipients remains unclear. We prospectively examined these associations among healthcare workers. This study included 1434 staff members at a tertiary hospital who completed a questionnaire and provided blood samples in December 2023. Participants were followed for SARS-CoV-2 and seasonal influenza infections until March 2024, based on data from an in-house registry and responses to a follow-up questionnaire. Baseline serum 25-hydroxyvitamin D levels were categorized as sufficient (≥20 ng/mL), insufficient (12-19 ng/mL), or deficient (

Concepts Keywords
Hospital 25-hydroxyvitamin D
Hydroxyvitamin Adult
Influenza COVID-19
Workers COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
Female
Health Personnel
Humans
Influenza Vaccines
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Proportional Hazards Models
Prospective Studies
Risk Factors
SARS-CoV-2
SARS-CoV-2
Seasonal influenza
Seasons
Twindemic
Vitamin D
Vitamin D
Vitamin D
Vitamin D Deficiency

Semantics

Type Source Name
drug DRUGBANK Vitamin D
pathway REACTOME Influenza Infection
drug DRUGBANK Etoperidone
disease IDO blood
disease MESH influenza
disease MESH infections
disease MESH COVID-19
disease MESH Vitamin D Deficiency

Original Article

(Visited 3 times, 1 visits today)